LOGIN  |  REGISTER
Assertio

Recent Insider Transactions - Janux Therapeutics (NASDAQ: JANX)

Follow NASDAQ:JANX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ JANX Janux Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director, 10 percent owner:
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Barrett Ronald W / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
CAPPS VICKIE L / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
DOBMEIER ERIC / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Gujrathi Sheila / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Hernday Natasha / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
McNulty Alana B. / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Simson Jake / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Kung Winston / director
06/11/2025
Buy
$25.46
11,667
$297K
11,667
NASDAQ JANX Janux Therapeutics
Doyle Janeen Noel / officer: Chief Corp. & Bus. Dev. Ofcr
06/02/2025
Buy
$25.01
154,000
$3.852M
154,000
NASDAQ JANX Janux Therapeutics
Meyer Andrew Hollman / officer: Chief Business Officer
05/01/2025
Sell
$4.21
3,333
$14K
87,332
NASDAQ JANX Janux Therapeutics
Meyer Andrew Hollman / officer: Chief Business Officer
05/01/2025
Buy
$4.21
3,333
$14K
85,472
NASDAQ JANX Janux Therapeutics
Meyer Andrew Hollman / officer: Chief Business Officer
05/01/2025
Sell
$31.95
2,933
$94K
82,539
NASDAQ JANX Janux Therapeutics
Meyer Andrew Hollman / officer: Chief Business Officer
05/01/2025
Sell
$32.60
400
$13K
82,139

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous